Identification of the lipid-binding cyanogen bromide fragment from the cystine-containing high density apolipoprotein, APOLP-GLN-II.
D000595:Amino Acid Sequence; D000596:Amino Acids / Q000032:analysis; D000818:Animals; D001059:Apoproteins / Q000032:analysis / Q000097:blood; D002417:Cattle; D002848:Chromatography, DEAE-Cellulose; D002850:Chromatography, Gel; D002942:Circular Dichroism; D003488:Cyanogen Bromide; D003553:Cystine / Q000032:analysis*; D004789:Enzyme Activation; D005973:Glutamine / Q000032:analysis; D006801:Humans; D006884:Hydroxybutyrate Dehydrogenase / Q000037:antagonists & inhibitors; D008074:Lipoproteins / Q000032:analysis*; D008075:Lipoproteins, HDL / Q000032:analysis / Q000097:blood; D008928:Mitochondria / Q000201:enzymology; D010713:Phosphatidylcholines; D011485:Protein Binding; D014461:Ultracentrifugation
D000596:Amino Acids; D001059:Apoproteins; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D010713:Phosphatidylcholines; D005973:Glutamine; D003553:Cystine; D006884:Hydroxybutyrate Dehydrogenase; D003488:Cyanogen Bromide